CME Group (CME) – Investment Analysts’ Recent Ratings Updates

CME Group (NASDAQ: CME) recently received a number of ratings updates from brokerages and research firms:

• 10/23/2026 – CME Group was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
• 10/22/2026 – CME Group had its “overweight” rating reaffirmed by Piper Sandler. They now have a $330.00 price target on the stock, up from $295.00.
• 10/22/2026 – CME Group had its price target raised by Wells Fargo & Company from $315.00 to $333.00. They now have an “overweight” rating on the stock.
• 10/22/2026 – CME Group had its price target raised by Morgan Stanley from $337.00 to $359.00. They now have an “overweight” rating on the stock.
• 10/22/2026 – CME Group was given a new $367.00 price target by CLSA.
• 10/22/2026 – CME Group had its price target raised by Barclays from $281.00 to $321.00. They now have an “equal weight” rating on the stock.
• 10/22/2026 – CME Group had its price target raised by UBS Group from $270.00 to $310.00. They now have a “neutral” rating on the stock.
• 10/22/2026 – CME Group was upgraded by JPMorgan Chase & Co. from “underweight” to “overweight”. They now have a $367.00 price target on the stock.
• 10/14/2026 – CME Group had its price target raised by Wells Fargo & Company from $301.00 to $315.00. They now have an “overweight” rating on the stock.
• 10/9/2026 – CME Group had its price target raised by Morgan Stanley from $330.00 to $337.00. They now have an “overweight” rating on the stock.
• 10/8/2026 – CME Group was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 10/7/2026 – CME Group had its price target raised by Barclays from $270.00 to $281.00. They now have an “equal weight” rating on the stock.
• 10/5/2026 – CME Group had its price target raised by TD Cowen from $292.00 to $300.00. They now have a “buy” rating on the stock.
• 10/5/2026 – CME Group had its price target raised by UBS Group from $260.00 to $270.00. They now have a “neutral” rating on the stock.
• 10/3/2026 – CME Group was upgraded by Wall Street Zen from “strong sell” to “sell”.
• 10/2/2026 – CME Group is now covered by Wells Fargo & Company. They set an “overweight” rating and a $301.00 price target on the stock.
• 10/1/2026 – CME Group is now covered by Wells Fargo & Company. They set an “overweight” rating and a $301.00 price target on the stock.
• 9/28/2026 – CME Group had its “buy” rating reaffirmed by TD Cowen. They now have a $292.00 price target on the stock.
• 9/3/2026 – CME Group had its “buy” rating reaffirmed by TD Cowen. They now have a $292.00 price target on the stock.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were given a $1.30 dividend. The ex-dividend date of this dividend was Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s payout ratio is presently 42.66%.

Insider Transactions at CME Group

In related news, Director Elizabeth Cook sold 500 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the transaction, the director owned 17,916 shares in the company, valued at $5,018,450.76. The trade was a 2.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Sunil Cutinho sold 5,000 shares of the stock in a transaction that occurred on Tuesday, October 27th. The shares were sold at an average price of $298.70, for a total transaction of $1,493,500.00. Following the sale, the insider directly owned 20,037 shares of the company’s stock, valued at $5,985,051.90. The trade was a 19.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 20,900 shares of company stock worth $5,871,155. 0.30% of the stock is owned by corporate insiders.

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.